<DOC>
	<DOCNO>NCT00315159</DOCNO>
	<brief_summary>The purpose study evaluate less invasive procedure evaluation inguinal ( groin ) nod patient primary squamous cell carcinoma vulva . Each patient undergo sentinel lymph node dissection well resection primary tumor vulva . Patients determine sentinel node negative metastatic disease receive full groin dissection . Patients sentinel lymph node contain metastasis undergo complete inguinal dissection . The study evaluate long-term outcome patient receive sentinel lymph node dissection without complete dissection . All patient enter onto study biopsy proven squamous cell carcinoma vulva . Each patient enrol Gynecologic Oncologist practice Women &amp; Infants Hospital</brief_summary>
	<brief_title>Conservative Management With Isolated Sentinel Lymph Node Biopsy Vulvar Cancer Patients .</brief_title>
	<detailed_description>Conservative Management Isolated Sentinel Lymph Node Biopsy Vulvar Cancer Patients Sentinel Lymph Nodes Determined Negative Metastatic Disease . Introduction The American Cancer Society estimate 4000 new case vulvar cancer year 2003 ( 1 ) . The majority patient undergo surgical therapy groin node dissection ass inguinal nodal chain evidence metastatic disease . For many year search less radical surgical approach evaluate inguinal lymphatic basin . The classic approach vulvar cancer en-bloc resection vulva groin single incision . This approach lead complication rate high 69 % chronic leg edema 85 % wound breakdown ( 2 ) . In effort reduce morbidity groin node dissection , triple incision technique introduce ( 3 ) . A GOG study evaluate limited surgery wide local excision superficial groin node dissection report rate chronic lymphedema 19 % wound infection separation 29 % ( 4 ) . In report penile carcinoma concept sentinel node first group nod inguinal lymphatic chain put forth Cabanas et al. ( 5 ) . Morton colleague advance technique sentinel node lymphatic mapping patient cutaneous melanoma ( 6 ) . In 1994 Levenback et al , describe use isosulfan blue dye detection sentinel node inguinal lymphatic chain ( 7 ) . To date , number study perform evaluate utility sentinel node technology application vulvar malignancy ( Table 1 ) ( 7-20 ) . For melanoma , sentinel node dissection become standard care evaluation lymphatic basin . Many cancer center , include Women Infants ' Hospital , use sentinel node dissection evaluation axillary node breast cancer patient standard care . This technology decrease rate chronic arm edema breast cancer patient . Inguinal node metastasis patient squamous cell carcinoma vulva report high 27 % ( 21 ) . Consequently , large number patient may undergo potentially morbid procedure without gain . Non-invasive method evaluation inguinofemoral node CT , MRI PET scan yet prove reliable . Sentinel node biopsy utilize Tc-99m sulfur colloid isosulfan blue dye allow evaluation nodal status patient vulvar malignancy minimally invasive surgery . Our study , Women Infants ' Hospital , employ Tc-99m sulfur colloid isosulfan blue dye identify sentinel node inguinal lymphatic chain patient primary squamous cell carcinoma vulva . Twenty nine patient enrol 107 sentinel node study false negative SLN report ( 22 ) There 175 patient report literature undergone SLN dissection evaluation inguinal lymphatic basin metastatic disease . To date false negative SLN report . We feel SLN dissection proven reliable safe procedure institution others around world . Further study need perform order evaluate use SLN dissection alone patient pathologic negative sentinel node metastasis . This study evaluate use sentinel node dissection alone management patient potentially need benefit full inguinal node dissection . Sentinel Node Concept Sentinel node dissection first apply evaluation inguinal nodal basins patient penile cancer ( 23 ) . The sentinel node concept base belief certain anatomical area drain individual nodal chain first lymph node chain sentinel node . It show sentinel node predictive status lymphatic basin presence metastatic disease non-sentinel node . The use lymphazurin blue dye technetium-99m sulfur colloid show reliably identify sentinel node many cancer ad melanoma , breast colon . This technology also study patient vulvar malignancy show detect sentinel node 100 % time ( 22 ) . With limited number sentinel node obtain lymphatic basin complete pathologic evaluation lymph node perform . The use ultra-staging ( serial sectioning ) allow small metastasis micrometastasis reliably detect . Sentinel lymph node technology allow complete surgical pathologic evaluation inguinal lymphatic basin potential benefit avoid complete inguinal node dissection patient SLN determine negative metastatic disease . Study Design This prospective trial examine conservative management patient inguinal sentinel node deem negative metastatic disease patient primary squamous cell carcinoma vulva . Number Patients : The goal study enroll 100 patient 5 year period follow total three year . Sentinel Lymph Node Technique : Each patient undergo two intradermal peritumoral injection total 2-3 mCi unfiltered technetium-99m sulfur colloid volume 1cc , within 24 hour prior surgery . These injection take place nuclear medicine suite Rhode Island Hospital Dr. Richard Noto 's supervision . Following injection Tc-99m sulfur colloid lymphoscintigram perform detect presence sentinel node . Intra-operatively , 5 10 minute prior groin dissection , 3 cc isosulfan blue dye inject peritumoral edge manner location similar Tc-99m sulfur colloid injection . An inguinal dissection perform radical excision vulvar tumor . Prior groin node incision , hand hold collimate gamma counter use identify location sentinel node . This area mark ink skin surface . An inguinal incision make inguinal lymphatic bed dissect identify blue afferent lymphatic tract and/or blue stain lymph node . A hand hold collimate gamma counter use detect lymph node increase activity , define count great 5 % injection site , groin incision . Also , lymph node blue lymphatic tract lead stain blue consider sentinel node . As well , lymph node identify hand hold gamma counter take Tc-99m sulfur colloid consider hot sentinel node . Each sentinel node evaluate 10 second gamma count label hot blue , hot non-blue cold blue . With completion sentinel node groin node dissection , lymphatic bed re-scanned gamma counter ensure sentinel node remove . Once SLN groin dissection complete incision close full groin dissection do separate sit pending pathologic evaluation sentinel lymph node . The remainder surgery treatment primary tumor complete current standard care procedure depend size location tumor . Pathologic Analysis Sentinel Lymph Nodes : Each sentinel lymph node serially section 2mm interval parallel long axis totally submit histologic evaluation one block . From block , five slide cut 100 micron interval stain hematoxylin eosin . A parallel slide level cut held batch cytokeratin AE1/AE3 immunohistochemical stain negative metastasis initial H &amp; E staining . The large dimension metastasis measure recorded order track presence micrometastasis define metastatic focus less 2mm size . Patient Management Protocol : Patients enrol sentinel lymph node protocol undergo sentinel lymph node dissection describe followed radical excision primary tumor . Patients sentinel node find contain metastatic disease primary vulvar malignancy go complete inguinal lymph node dissection per standard care . Patients sentinel lymph node deem negative metastatic disease base ultra-staging H &amp; E stain follow conservative management ( groin node dissection ) . Each patient follow clinically 3 month interval first three year total study follow period three year . Any patient determine groin recurrence treat current standard care modality appropriate recurrence . Published data document 5-7 % unanticipated groin failure patient negative lymphadenectomies use comparative outcome ( 25 ) .</detailed_description>
	<mesh_term>Vulvar Neoplasms</mesh_term>
	<criteria>1 . Patient age 18 year . 2 . Biopsy proven squamous cell carcinoma vulva . 3 . Depth invasion 1mm great . 4 . Patients groin clinically negative nodal metastasis . 5 . Patients candidate groin dissection . 1 . Any patient age 18 2 . Patients clinically suspicious groin node metastatic disease . 3 . Patients nonsquamous cell vulvar lesion . 4 . Depth invasion less 1mm . 5 . Patients refuse sign inform consent form .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Squamous</keyword>
	<keyword>Cell</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Vulva</keyword>
	<keyword>Sentinel Node</keyword>
</DOC>